Clinical Trials Logo

Filter by:
NCT ID: NCT04906824 Recruiting - Clinical trials for Peripheral Vessel Reconstruction

Post-Market Registry in Europe and US for the Use of VascuCelTM

VascuCel
Start date: June 9, 2023
Phase:
Study type: Observational

This is a post-market, multi-centre, open-label registry designed to collect prospective safety and performance data on the use of VascuCel in patients who require great vessel reconstruction, peripheral vascular reconstruction or suture line buttressing. This registry will collect safety and performance data up to 2 years following implantation.

NCT ID: NCT04906291 Completed - Caries Clinical Trials

The Preventive Effect of 2-years Use of Hydroxyapatite Containing Toothpastes in Children.

Start date: February 1, 2018
Phase: N/A
Study type: Interventional

The aim of this RCT was to verify the caries preventive efficacy of toothpastes containing biomimetic hydroxyapatite (H.A.) complex in children compared to traditional fluoridated toothpastes. In total 610 children of two age groups (4-5 years and 6-7 years at baseline) were enrolled. Four toothpastes, two containing fluoride-substituted hydroxyapatite (H.A.F.) (1000 and 1450 ppm F-) and magnesium-, strontium-, carbonate-substituted hydroxyapatite, in a chitosan matrix and two traditional fluoridated toothpastes (1000 and 1450 ppm F-) without other active components were administered randomly to two groups with younger children (Gyoung) and to two groups with older children those containing1450 ppm F (GOLD) during 24 months. A standardized questionnaire was administered to parents/caregivers to gain information regarding caries risk factors. Caries evaluation was performed at school using ICDAS, scoring lesions as initial (up to score 2), moderate (scores 3-4) and severe (scores 5-6).

NCT ID: NCT04905875 Recruiting - COVID-19 Pneumonia Clinical Trials

Prone Positioning for Invasively Ventilated Patients With COVID-19 Registry

PROVENT-C19
Start date: December 1, 2020
Phase:
Study type: Observational

SARS-CoV-2 infection is characterized mainly by moderate/severe pneumonia associated with progressive endothelial damage and coagulopathy. Acute respiratory failure among COVID-19 occurs in 42% of patients with COVID-19 pneumonia, and 61-81% of patients requiring intensive care . Among the suggested treatments for the management of ARDS patients, prone position (PP) can be used as an adjuvant therapy for improving ventilation in these patients, as recommended in the Surviving Sepsis Campaign COVID-19 guidelines. Nevertheless, no data is currently available on application and feasibility of PP in invasively ventilated patients with COVID-19 on their outcomes.

NCT ID: NCT04905823 Completed - Type 1 Diabetes Clinical Trials

Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D)

CoVaxT1D
Start date: March 31, 2021
Phase:
Study type: Observational

Given the high risk of severe SARS-CoV-2 infection, patients with T1D and T2D should represent a priority group to receive the SARS-CoV-2 vaccine. There are currently no studies on diabetic population response to mRNA COVID-19 vaccines. Therefore, in this observational cohort study, investigators will retrospectively analyze the safety and immunogenicity of the mRNA vaccines in eliciting both the humoral and cellular immune response in a subset of patients with T1D who already underwent blood sampling for measuring humoral response against SARSCoV2 for healthcare purposes and based on the clinical practice guidelines. Results will be compared with those obtained in non-diabetic individuals or in patients with non-autoimmune diabetes (T2D).

NCT ID: NCT04905693 Enrolling by invitation - Clinical trials for Idiopathic Pulmonary Fibrosis

Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

TETON-OLE
Start date: September 6, 2022
Phase: Phase 3
Study type: Interventional

Study RIN-PF-302 is designed to evaluate the long-term safety and tolerability of inhaled treprostinil in subjects with idiopathic pulmonary fibrosis.

NCT ID: NCT04905394 Completed - Bone Marrow Edema Clinical Trials

Clinical and Radiological Outcomes of Subchondroplasty in the Treatment of Bone Marrow Edema of the Knee

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

Bone marrow lesions (BMLs) of the knee are common subchondral defects, often associated with pain and functional limitation. Subchondroplasty is a percutaneous procedure in which calcium phosphate is injected inside BML areas, ensuring stability and promoting the deposition of new bone. Primary outcome of this study was to obtain a reduction of the Numeric Rating Scale score of 4 points or more at 6 months follow-up in more than 75% of patients. The secondary outcome was to evaluate the osteoarthritic and bone marrow structure evolution in the months after the procedure.

NCT ID: NCT04905264 Recruiting - Clinical trials for Brain Injuries, Acute

Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care

Start date: January 3, 2022
Phase:
Study type: Observational

The main purpose of this project is to identify the medium-term prognostic factors for patients with Severe Acquired Brain Injuries and evaluate their impact. The secondary aim is to create a system of continuous assessment of the quality of care for each rehabilitation unit.

NCT ID: NCT04905069 Recruiting - Prostate Cancer Clinical Trials

Effectiveness of the SpaceOAR Vue System in Subjects With Prostate Cancer Being Treated With Stereotactic Body Radiotherapy

SABRE
Start date: December 21, 2021
Phase: N/A
Study type: Interventional

To demonstrate the effectiveness of the SpaceOAR Vue System in reducing late gastrointestinal (GI) toxicity in subjects undergoing Stereotactic Body Radiotherapy (SBRT) to treat prostate cancer.

NCT ID: NCT04904978 Completed - Clinical trials for Extrinsic Staining of Tooth - Medication

Evaluation of Two Different Toothpastes for Clinical Management of Extrinsic Stains.

Start date: May 28, 2021
Phase: N/A
Study type: Interventional

The aim of the study is to assess the efficacy of Blanx Black Toothpaste against extrinsic stains of teeth. Patients who sign the informed consent will participate to the study. At the baseline, the collection of Plaque Index, modified Lobene index and Bleeding Index will be performed, giving the instruction for a proper home oral hygiene. Professional supragingival and subgingival dental hygiene with piezoelectric will be performed. Then, patients will be randomly divided into two groups: - Trial Group will use Blanx Black Toothpaste (2 minutes brushing) twice a day for the all the study duration; - Control Group will use Colgate Sensation White Toothpaste (2 minutes brushing) twice a day. Patients will be reevaluated after 10 days, after 1 month and after 3 months, collecting again the indices and improving home oral care.

NCT ID: NCT04904731 Completed - Clinical trials for COVID-19 Respiratory Infection

Effects of Body Position on Diaphragmatic Activity in Patients Requiring Noninvasive Ventilation for Acute Respiratory Failure COVID-19 Related

DiaCOVIDProne
Start date: February 19, 2021
Phase:
Study type: Observational

The present investigation aims to assess the diaphragmatic thickening fraction, reflecting the diaphragmatic activity, during supine (baseline) and at 1 hour following prone position in patients assisted through non invasive ventilation due to hypoxemic acute respiratory failure related to COVID-19. Also, the impact of lung aeration and comfort were ascertained in the same setting